Literature DB >> 30332601

Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

J Curtis Nickel1, Lorne Aaron2, Jack Barkin3, Dean Elterman4, Mahmoud Nachabé2, Kevin C Zorn5.   

Abstract

Entities:  

Year:  2018        PMID： 30332601      PMCID： PMC6192748          DOI： 10.5489/cuaj.5616

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  84 in total

1.  Finasteride: a long-term follow-up in the treatment of recurrent hematuria associated with benign prostatic hyperplasia.

Authors:  D Delakas; E Lianos; I Karyotis; A Cranidis
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

2.  Transurethral resection of prostate with plasmakinetic energy: 100 months results of a prospective randomized trial.

Authors:  Ahmet Y Muslumanoglu; Emrah Yuruk; Murat Binbay; Tolga Akman
Journal:  BJU Int       Date:  2011-11-24       Impact factor: 5.588

Review 3.  Prostatic stents for the treatment of benign prostatic hyperplasia.

Authors:  Brian A Vanderbrink; Ardeshir R Rastinehad; Gopal H Badlani
Journal:  Curr Opin Urol       Date:  2007-01       Impact factor: 2.309

4.  Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.

Authors:  Steffen Rausch; Thomas Heider; Jens Bedke; Stephan Kruck; Christian Schwentner; Karsten Fischer; Arnulf Stenzl; Tilman Kälble
Journal:  Urology       Date:  2015-01       Impact factor: 2.649

Review 5.  Alpha adrenoceptor antagonists in the year 2000: is there anything new?

Authors:  C R Chapple
Journal:  Curr Opin Urol       Date:  2001-01       Impact factor: 2.309

Review 6.  Pygeum africanum for benign prostatic hyperplasia.

Authors:  T Wilt; A Ishani; R Mac Donald; I Rutks; G Stark
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Prostatic Arterial Embolization vs Open Prostatectomy: A 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities.

Authors:  Giorgio Ivan Russo; Dmitry Kurbatov; Salvatore Sansalone; Alexander Lepetukhin; Sergey Dubsky; Ivan Sitkin; Costanza Salamone; Livio Fiorino; Roman Rozhivanov; Sebastiano Cimino; Giuseppe Morgia
Journal:  Urology       Date:  2015-07-18       Impact factor: 2.649

8.  The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries.

Authors:  Annie Hutchison; Richard Farmer; Katia Verhamme; Richard Berges; Remigio Vela Navarrete
Journal:  Eur Urol       Date:  2006-06-27       Impact factor: 20.096

9.  Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Authors:  Kevin T McVary; Steven N Gange; Marc C Gittelman; Kenneth A Goldberg; Kalpesh Patel; Neal D Shore; Richard M Levin; Michael Rousseau; J Randolf Beahrs; Jed Kaminetsky; Barrett E Cowan; Christopher H Cantrill; Lance A Mynderse; James C Ulchaker; Thayne R Larson; Christopher M Dixon; Claus G Roehrborn
Journal:  J Urol       Date:  2015-11-22       Impact factor: 7.450

10.  Clinical features, complications, and incidence of intraoperative floppy iris syndrome in patients taking tamsulosin.

Authors:  T Takmaz; I Can
Journal:  Eur J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 2.597
View more
  22 in total

1.  A shared decision: Bipolar vs. monopolar transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  Naeem Bhojani; Kevin C Zorn; Dean Elterman
Journal:  Can Urol Assoc J       Date:  2020-12       Impact factor: 1.862

2. 

Authors:  Elliot Lass; Lucshman Raveendran
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

3.  Educational implications of changing the guidelines for the digital rectal examination.

Authors:  Elliot Lass; Lucshman Raveendran
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

4.  DrillCutTM vs VersaCutTM prostate tissue morcellation devices after holmium laser enucleation: A prospective, randomized controlled trial.

Authors:  Ahmed Ibrahim; Mostafa M Elhilali; Mohammed A Elkoushy; Sero Andonian; Serge Carrier
Journal:  Can Urol Assoc J       Date:  2018-12-03       Impact factor: 1.862

5.  Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP.

Authors:  David-Dan Nguyen; Vincent Misraï; Thorsten Bach; Naeem Bhojani; James E Lingeman; Dean S Elterman; Kevin C Zorn
Journal:  World J Urol       Date:  2020-03-02       Impact factor: 4.226

6.  Reasons to believe in vaporization: a review of the benefits of photo-selective and transurethral vaporization.

Authors:  Russell N Schwartz; Felix Couture; Iman Sadri; Adel Arezki; David-Dan Nguyen; Ahmed S Zakaria; Kyle Law; Dean Elterman; Malte Rieken; Hannes Cash; Kevin C Zorn
Journal:  World J Urol       Date:  2020-09-15       Impact factor: 4.226

7.  Aquablation among novice users in Canada: A WATER II subpopulation analysis.

Authors:  Kevin C Zorn; S Larry Goldenberg; Ryan Paterson; Alan So; Dean Elterman; Naeem Bhojani
Journal:  Can Urol Assoc J       Date:  2018-10-15       Impact factor: 1.862

8.  Comparison of < 100 cc prostates and > 100 cc prostates undergoing aquablation for benign prostatic hyperplasia.

Authors:  N Bhojani; D-D Nguyen; R P Kaufman; D Elterman; K C Zorn
Journal:  World J Urol       Date:  2018-10-28       Impact factor: 4.226

9.  Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety.

Authors:  Kyle W Law; Côme Tholomier; David-Dan Nguyen; Iman Sadri; Félix Couture; Ahmed S Zakaria; David Bouhadana; Franck Bruyère; Hannes Cash; Maximilian Reimann; Luca Cindolo; Giovanni Ferrari; Carlos Vasquez-Lastra; Tiago J Borelli-Bovo; Edgardo F Becher; Vincent Misrai; Dean Elterman; Naeem Bhojani; Kevin C Zorn
Journal:  World J Urol       Date:  2021-04-10       Impact factor: 4.226

10.  Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.